Concord Biotech Limited (NSE:CONCORDBIO)
India · Delayed Price · Currency is INR 1,321.30
-16.30 (-1.22%)
Jun 23, 2026, 3:10 PM IST
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 139.93 billion as of June 23, 2026. Its market cap has decreased by -27.10% in one year.
Market Cap
139.93B
Enterprise Value
135.78B
Revenue
10.55B
Ranking
n/a
PE Ratio
53.98
Stock Price
1,321.30
Market Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 139.93B, an increase of 41.88%. That is a compound annual growth rate of 13.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 139.93B | -0.59% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 672.43B |
| Anthem Biosciences | 430.28B |
| OneSource Specialty Pharma | 184.42B |
| Blue Jet Healthcare | 90.46B |
| Supriya Lifescience | 75.03B |
| Zota Health Care | 47.43B |
| Panacea Biotec | 32.85B |
| Dishman Carbogen Amcis | 26.77B |